European Association for the Study of Diabetes (EASD) 2021 virtual congress highlights

EASD 2021 logo 300x165px

Learn more about the future of GLP-1 analogues, their cardiorenal benefits and more in this comprehensive report on the 2021 EASD conference.

You will learn:
Important considerations from the 2021 ADA/EASD consensus report regarding the care and management of type 1 diabetes
The latest evidence on weekly basal insulin analogues currently under development
The role of genetics and the environment in the development of vascular complications in the diabetic patient
Cardiorenal benefits and the future of GLP-1 receptor agonists
Current understanding of the role of cell ageing in the development of diabetes
An enhanced understanding of the increased risks of diabetic patients infected with SARS-CoV-2.


ATTENTIONKindly note that if you attended the live webinar, you have already received 1 CPD point and will not be permitted to receive additional points for the report. Should this occur, the HPCSA will only record the 1 CPD point from the live webinar, invalidating any additional CPD points from the report. Please note deNovo Medica ensures uploading of your CPD points to the HPCSA: please don’t upload these yourself.

To access this module, please register or login: